| Execution period | Financial year 2026-27 |
|---|
BSE filing, NSE: JDORGOCHEM. Summary written from the filing by ALFA Finder's alert engine.
Jaysynth Orgochem Ltd: key numbers
- Share price
- ₹14.02
- Market cap
- ₹189.1 Cr
- Revenue (annual)
- ₹259.7 Cr
- Net profit (annual)
- ₹14.66 Cr
- P/E (TTM)
- 10.3×Sector 34.1×
- Promoter holding
- 73.68%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jaysynth Orgochem Ltd
All →Jaysynth Orgochem Other Announcement
Jaysynth Orgochem Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Jaysynth Orgochem Management Change
Jaysynth Orgochem Limited has appointed M/s. Chhogmal & Co. as its Statutory Auditor for a term of 60 months effective September 28, 2026.
Jaysynth Orgochem Other Announcement
Jaysynth Orgochem Limited has appointed M/s. Chhogmal & Co. as its Statutory Auditor for a five-year term, following approval at the 52nd Annual General Meeting.
Jaysynth Orgochem Annual General Meeting
Jaysynth Orgochem Limited held its 52nd Annual General Meeting on September 28, 2026, where shareholders transacted ordinary and special business, including dividend declarations.
Jaysynth Orgochem Other Announcement
Jaysynth Orgochem Limited shared the web link for its 52nd AGM notice and Annual Report for FY 2025-26 with unregistered shareholders as required by regulation.
Jaysynth Orgochem Annual General Meeting
Jaysynth Orgochem Limited has issued the notice for its 52nd Annual General Meeting, scheduled for September 28, 2026. The meeting will address financial statements and dividend declarations.
Other other announcement announcements
All →Robokidz Eduventures Other Announcement
Robokidz Eduventures filed its quarterly shareholding pattern for the period ended 30 September 2026. This is routine SEBI Regulation 31 disclosure with no transaction or corporate event.
Natco Pharma Other Announcement
Natco Pharma filed its shareholding pattern with a reporting date of 23 October 2026. Promoter and promoter group hold about 46% of total equity.
Innomet Advanced Materials Other Announcement
Innomet Advanced Materials filed its half-year Reg 32 statement on preferential issue proceeds, with no deviation. Rs.753.25 lakh raised in August 2026 was fully used for working capital.
CCME Global Other Announcement
CCME Global disclosed insider trades by two connected persons, acquiring 90 lakh and 22.5 lakh shares on 28 October 2026. Combined consideration is stated as Rs.112.50 Crore.
- Value
- ₹112.5 Cr
Jay Jalaram Technologies Other Announcement
Jay Jalaram Technologies named its KMP as authorised persons for materiality determination under Regulation 30. This administrative listing carries no financial or business impact.
SPR Auto Technologies Other Announcement
SPR Auto Technologies filed its quarterly QIP monitoring agency report for the quarter ended September 30, 2026. The report found no deviation from the issue objects.